SECreport

Form 4 ELITE PHARMACEUTICALS For: Oct 23 Filed by: Plassche Douglas

Elite Pharmaceuticals, Inc.  (ELTP) 
NASDAQ:AMEX Investor Relations: ir.elitepharma.com